AbbVie Calls Docs Sought In Pay-For-Delay Suit Privileged

AbbVie Inc. and Besins Healthcare Inc. told a Pennsylvania federal judge Friday that documents requested by the Federal Trade Commission in a pay-for-delay suit over testosterone replacement treatment AndroGel are privileged...

Already a subscriber? Click here to view full article